Nephros (NASDAQ:NEPH – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Thursday, March 6th. Analysts expect Nephros to post earnings of ($0.01) per share and revenue of $3.57 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.
Nephros Trading Up 4.8 %
NEPH opened at $1.53 on Thursday. The stock has a market cap of $16.13 million, a PE ratio of -17.00 and a beta of 1.19. Nephros has a twelve month low of $1.36 and a twelve month high of $3.55. The business’s 50 day moving average is $1.55 and its 200-day moving average is $1.61.
Analysts Set New Price Targets
Separately, Benchmark reissued a “speculative buy” rating and set a $5.00 target price on shares of Nephros in a research note on Tuesday, November 12th.
Nephros Company Profile
Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
Further Reading
- Five stocks we like better than Nephros
- How to Read Stock Charts for Beginners
- Buffett’s on the Sidelines – Should You Follow?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.